High Blood Pressure in the Lungs in Dogs (Pulmonary Hypertension, PH)
- Occurrence: rarer
- Location of disease: Chest
When to visit the vet?
Urgent see a veterinarian within 24 hours
If the condition worsens / symptoms persist, consult a veterinarian.
Definition
Pulmonary hypertension in dogs is a condition in which blood pressure in the pulmonary arteries is elevated, which can lead to heart overload and ultimately to heart failure.
Das Wichtigste auf einen Blick
Pulmonary hypertension in dogs is a condition in which blood pressure in the arteries between the heart and lungs is elevated. This can be caused by narrowing or blockages in these arteries, forcing the heart to work harder to pump blood through the lungs. The most common causes include chronic lung diseases triggered by infections, Inflammatory conditions, or allergies, as well as heart diseases that often cause blood to back up into the lungs. Thromboembolic diseases, in which blood clots block the pulmonary arteries, can also play a role.
Symptoms include Congestive heart failure, reduced exercise tolerance, Respiratory distress, and occasionally bluish mucous membranes. Cough and Weight loss are also common, while brief periods of unconsciousness occur less frequently. Diagnosis requires a thorough clinical examination, often supplemented by echocardiography, X-rays, and blood tests. In some cases, cardiac catheterization may be necessary to measure blood pressure directly.
Treatment aims to relieve symptoms and address the causes. Medications such as phosphodiesterase inhibitors and diuretics are commonly used to lower blood pressure and support heart function. In acute cases, oxygen therapy may be required. The prognosis varies depending on severity and cause, with early diagnosis and treatment improving the chances of a good quality of life. Preventive measures focus on treating heart and lung disease, as well as a healthy lifestyle with regular exercise and a balanced diet.
Ursachen
Pulmonary hypertension occurs when blood pressure rises in the arteries that connect the heart to the lungs. This can be caused by narrowing or blockage of these arteries, which restricts blood flow and forces the heart to work harder to pump blood through the lungs.
The causes of pulmonary hypertension in dogs are varied. One of the most common causes is chronic lung disease, which leads to reduced oxygen uptake. This can be triggered by infections, Inflammatory conditions, or allergies.
Heart disease, especially conditions affecting the left ventricle, can also lead to pulmonary hypertension. With these conditions, blood often backs up into the lungs, increasing pressure in the pulmonary arteries.
Another factor can be so-called thromboembolic disease, in which blood clots block the pulmonary arteries. These clots can form as a result of surgery, traumas, or blood clotting disorders.
Symptoms
Symptoms of pulmonary hypertension in dogs are often non-specific and can easily be confused with those of other conditions. A common symptom is Respiratory distress or rapid, shallow breathing, which occurs especially during exertion or stress.
Cough, especially a dry, persistent cough, can also be a sign of pulmonary hypertension. Dogs with this condition often show reduced exercise tolerance and become exhausted more quickly than usual.
Another symptom may be blue or pale gums, which indicates a lack of oxygen in the blood. In advanced cases, fainting or collapse may occur, especially when the dog is excited or active.
Diagnose
Diagnosis of pulmonary hypertension in dogs requires a thorough clinical examination as well as specific diagnostic tests. An important part of the diagnosis is echocardiography, an ultrasound examination of the heart that helps measure pressure in the pulmonary arteries and identify structural heart problems.
Additionally, a chest X-ray may be performed to detect anomalies in the lungs and heart. Blood tests can also be helpful to rule out other underlying conditions that could cause pulmonary hypertension.
In some cases, cardiac catheterization may be required to measure blood pressure directly in the pulmonary arteries. However, this is an invasive test that is only performed if other methods do not provide clear results.
Therapie
Treatment for pulmonary hypertension in dogs aims to relieve symptoms and address the underlying causes. Drug therapy is often necessary to lower blood pressure in the pulmonary arteries and support heart function.
Commonly used medications include phosphodiesterase inhibitors such as sildenafil, which dilate the blood vessels in the lungs and reduce pressure in the pulmonary vessels. Diuretics may be prescribed to remove excess fluid from the body and reduce strain on the heart.
Oxygen therapy may be needed in acute cases to increase the oxygen level in the blood. Careful monitoring and adjustment of therapy by the veterinarian is crucial to achieve the best possible results.
Prognose und Nachsorge
The prognosis for dogs with pulmonary hypertension varies depending on the severity of the disease and the underlying cause. In some cases, the condition can be well controlled through early diagnosis and treatment, allowing dogs to maintain a good quality of life.
In more severe cases, or if the condition is not treated in time, the prognosis may be unfavorable as heart function continues to decline and can eventually lead to heart failure.
Regular veterinary check-ups and ongoing adjustment of therapy are crucial to improve the prognosis and slow disease progression.
Prävention
prevention of pulmonary hypertension in dogs mainly focuses on preventing and treating conditions that increase the risk of developing high blood pressure in the lungs. Early detection and treatment of heart and lung disease can help reduce the risk.
A healthy lifestyle, including regular exercise and a balanced diet, can also help reduce the risk of cardiovascular disease.
Regular veterinary examinations are important to detect signs of heart or lung disease early. Proactive monitoring and care can help maintain the dog’s health in the long term.
Ausblick auf aktuelle Forschung
Pulmonary hypertension is not a single disease, but a syndrome with various causes in which the pressure in the pulmonary circulation rises pathologically. This primarily puts strain on the right ventricle. Modern research therefore no longer views the disease solely as a pressure problem, but as an interaction of vascular remodeling, inflammation, coagulation, impaired vascular regulation, and right heart strain. (pubmed.ncbi.nlm.nih.gov, pubmed.ncbi.nlm.nih.gov)
A central research outlook lies in earlier diagnosis and more accurate risk classification. Today, intensive work is being done to better combine imaging, stress tests, biomarkers, and clinical progress data to identify patients earlier and predict the course of the disease more precisely. Particularly important is the question of how well the function of the right heart can be preserved, as it significantly influences the prognosis. (pubmed.ncbi.nlm.nih.gov, pubmed.ncbi.nlm.nih.gov)
Therapeutically, the outlook is currently particularly exciting. In addition to the established signaling pathways of endothelin, nitric oxide, and prostacyclin, new approaches have been added. A major advance is sotatercept for certain forms of pulmonary arterial hypertension, because here, for the first time, pathological vascular remodeling processes are specifically targeted rather than just influencing vessel width. (fda.gov, pubmed.ncbi.nlm.nih.gov)
Overall, research is clearly moving toward earlier detection, better phenotyping, and disease-modifying therapy instead of pure symptom management.
Frequently Asked Questions (FAQs)
1. What is pulmonary hypertension?
2. What are the causes?
3. What symptoms does an affected dog show?
4. How is the diagnosis made?
5. Which breeds are predisposed?
6. How is pulmonary hypertension treated?
7. How does sildenafil work?
8. Can the disease be cured?
9. What is the Prognose?
10. How are follow-up checks performed?
Literatur
- Reinero, C., Visser, L. C., Kellihan, H. B., Masseau, I., Rozanski, E., Clercx, C., Williams, K., Abbott, J., Borgarelli, M., & Scansen, B. A. (2020). ACVIM consensus statement guidelines for the diagnosis, classification, treatment, and monitoring of pulmonary hypertension in dogs. Journal of Veterinary Internal Medicine, 34(2), 549–573. https://doi.org/10.1111/jvim.15725
- Jaffey, J. A., Wiggen, K., Leach, S. B., Masseau, I., Girens, R. E., & Reinero, C. R. (2019). Pulmonary hypertension secondary to respiratory disease and/or hypoxia in dogs: Clinical features, diagnostic testing and survival. The Veterinary Journal, 251, Article 105347. https://doi.org/10.1016/j.tvjl.2019.105347
- Johnson, L. R., & Stern, J. A. (2020). Clinical features and outcome in 25 dogs with respiratory-associated pulmonary hypertension treated with sildenafil. Journal of Veterinary Internal Medicine, 34(1), 65–73. https://doi.org/10.1111/jvim.15679
- Bach, J. F., Rozanski, E. A., MacGregor, J., Betkowski, J. M., & Rush, J. E. (2006). Retrospective evaluation of sildenafil citrate as a therapy for pulmonary hypertension in dogs. Journal of Veterinary Internal Medicine, 20(5), 1132–1135. https://doi.org/10.1111/j.1939-1676.2006.tb00711.x
- Kellum, H. B., & Stepien, R. L. (2007). Sildenafil citrate therapy in 22 dogs with pulmonary hypertension. Journal of Veterinary Internal Medicine, 21(6), 1258–1264. https://doi.org/10.1892/07-006.1
- Jaffey, J. A., Leach, S. B., Kong, L. R., Wiggen, K. E., Bender, S. B., & Reinero, C. R. (2019). Clinical efficacy of tadalafil compared to sildenafil in treatment of moderate to severe canine pulmonary hypertension: A pilot study. Journal of Veterinary Cardiology, 24, 7–19. https://doi.org/10.1016/j.jvc.2019.05.001
- Kellihan, H. B., & Stepien, R. L. (2010). Pulmonary hypertension in dogs: Diagnosis and therapy. Veterinary Clinics of North America: Small Animal Practice, 40(4), 623–641. https://doi.org/10.1016/j.cvsm.2010.03.011